An Off-the-Shelf Multivalent Vaccine Containing Cancer’s Dark Matter, DPV-001, Combined with PD-1 +/- GITR in Head & Neck Cancer: Safety, Efficacy, and Immunodynamics from the Phase 1 GITRVax Trial.

An Off-the-Shelf Multivalent Vaccine Containing Cancer’s Dark Matter, DPV-001, Combined with PD-1 +/- GITR in Head & Neck Cancer: Safety, Efficacy, and Immunodynamics from the Phase 1 GITRVax Trial. These data will be presented by Rom S. Leidner, M.D., during the First-in-Human Phase I Clinical Trials Session 1 on April 8 (No. CT112, Poster Section 48, 1:30 to 5pm), at the American Association for Cancer Research Annual Meeting held 5-10 April in San Diego, CA. Bernie Fox April 3, 2024 Facebook 0 Twitter 0 Likes Next UbiVac Announces Preliminary Immunological Data from 1st-In-Human Trial of DPV-001 Immunotherapy Trio for Advanced HNSCC Bernie Fox February 1, 2024 #block-yui_3_17_2_1_1600978183318_3705 { --social-icons-justify-content: center; --social-icons-dimension: 20px;--social-icons-gap: 12px; } #block-yui_3_17_2_1_1600978183318_3705 .sqs-svg-icon--wrapper { --si-border-radius: 0;--si-scale: 2;--si-box-shadow: none;--si-fill-icon: var(--si-primary);--si-fill-icon-fade: var(--si-primary-faded);--si-fill-icon-hover: var(--si-primary);--si-fill-mask: transparent;--si-fill-mask-fade: transparent;--si-fill-mask-hover: transparent;--si-bg: transparent;--si-bg-fade: transparent;--si-bg-hover: transparent; } #block-yui_3_17_2_1_1600978183318_3705 .sqs-svg-icon--list { justify-content: var(--social-icons-justify-content, center); column-gap: var(--social-icons-gap, 12px); row-gap: var(--social-icons-gap, 12px); } #block-yui_3_17_2_1_1600978183318_3705 .sqs-svg-icon--wrapper { width: var(--social-icons-dimension, 20px); height: var(--social-icons-dimension, 20px); margin: 0; border: none; background-color: var(--si-bg, transparent); box-shadow: var(--si-box-shadow, none); border-radius: var(--si-border-radius, 0); } #block-yui_3_17_2_1_1600978183318_3705 .sqs-svg-icon--wrapper > div { transform: scale(var(--si-scale, 1)); } #block-yui_3_17_2_1_1600978183318_3705 .sqs-use--icon { fill: var(--si-fill-icon, transparent); } #block-yui_3_17_2_1_1600978183318_3705 .sqs-use--mask { fill: var(--si-fill-mask, transparent); } #block-yui_3_17_2_1_1600978183318_3705 .sqs-svg-icon--list:hover .sqs-svg-icon--wrapper { background-color: var(--si-bg-fade, var(--si-bg, transparent)); } #block-yui_3_17_2_1_1600978183318_3705 .sqs-svg-icon--list:hover .sqs-svg-icon--wrapper .sqs-use--icon { fill: var(--si-fill-icon-fade, var(--si-fill-icon, transparent)); } #block-yui_3_17_2_1_1600978183318_3705 .sqs-svg-icon--list:hover .sqs-svg-icon--wrapper .sqs-use--mask { fill: var(--si-fill-mask-fade, var(--si-fill-mask, transparent)); } #block-yui_3_17_2_1_1600978183318_3705 .sqs-svg-icon--list:hover .sqs-svg-icon--wrapper:hover { background-color: var(--si-bg-hover, var(--si-bg, transparent)); } #block-yui_3_17_2_1_1600978183318_3705 .sqs-svg-icon--list:hover .sqs-svg-icon--wrapper:hover .sqs-use--icon { fill: var(--si-fill-icon-hover, var(--si-fill-icon, transparent)); } #block-yui_3_17_2_1_1600978183318_3705 .sqs-svg-icon--list:hover .sqs-svg-icon--wrapper:hover .sqs-use--mask { fill: var(--si-fill-mask-hover, var(--si-fill-mask, transparent)); } #block-yui_3_17_2_1_1600978183318_3705 { } #block-yui_3_17_2_1_1600978183318_3705 .sqs-block-socialaccountlinks-content { } #block-yui_3_17_2_1_1600978183318_3705 { mix-blend-mode: var(--tweak-social-links-block-blend); border-radius: var(--tweak-social-links-block-radius); } @media screen and (max-width: 767px) { #block-yui_3_17_2_1_1600978183318_3705 { } } @media screen and (max-width: 767px) { #block-yui_3_17_2_1_1600978183318_3705 .sqs-block-socialaccountlinks-content { } } @media screen and (max-width: 767px) { } © 2020 UbiVac | All rights reserved.

The release as fetched from its publisher. ubivac.com ↗